Dr. Reddy’s Laboratories Ltd (RDY) has released an update.
Dr. Reddy’s Laboratories Ltd has announced a strategic joint venture with Nestlé India to enhance their nutraceuticals offerings, with Dr. Reddy’s holding a 51% majority stake. Additionally, there has been a leadership shake-up with Mr. Marc Kikuchi stepping down as CEO of North America Generics, and Mr. Milan Kalawadia taking over the role, effective May 25, 2024. These moves are poised to strengthen the company’s position in India’s health supplement space and its organizational leadership.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
